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Background
Psychological morbidity is associated with frequent asthma
exacerbations, higher health care utilization, as well as
near-fatal and fatal asthma. The prevalence of psychologi-
cal comorbidities in patients with severe asthma is not
well-studied. The aim of our study was to evaluate the pre-
valence of anxiety, depression and hyperventilation, and
correlate these symptoms with asthma control,
exacerbation frequency and lung function in severe
asthmatics.
Methods
Patients who fulfilled the WHO definition of “treatment-
resistant severe asthma” (at least combination high-dose
inhaled corticosteroids and long-acting beta agonists) were
included. Patients literate in English completed the Hospi-
tal Anxiety and Depression Scale (HADS) and Nijmegen
Questionnaire during a regular doctor’s visit at our Severe
Asthma clinic. The HADS questionnaire comprises 7
anxiety and 7 depression questions. A cut-off score of ≥8
indicates a probable case of anxiety or depression. Nijme-
gen Questionnaire is a screening instrument for
hyperventilation. A score of ≥23 suggests hyperventilation.
Relation between these scores and Asthma Control Test,
exacerbation frequency, health care utilization and lung
function test results were analyzed.
Results
52 patients were included in the analysis: 24 (46.2%) male,
mean age 37.5 ±16.6 years, mean ACT score 16.8 ±4.5.
The prevalence of anxiety was 44.2%, depression was
19.2% and hyperventilation was 28.8%. Patients with anxi-
ety were more likely to have uncontrolled asthma (defined
as Asthma Control Test score of 19 or less) compared to
those without (87.0% vs. 51.7%, p=0.009). Similarly,
patients with hyperventilation were more likely to have
uncontrolled asthma compared to those without (93.3%
vs. 56.8%, p=0.011). There was no association between
depression and asthma control. Patients with anxiety had
lower FEV1 % predicted compared to those without (69.4
±17.2% vs. 81.2±21.2%, p=0.036). There was no association
between depression or hyperventilation and FEV1. No
association was found between anxiety, depression or
hyperventilation and frequency of asthma exacerbations.
Conclusion
A high prevalence of anxiety, hyperventilation and
depression exists amongst our severe asthmatics. Hyper-
ventilation and anxiety were associated with uncon-
trolled asthma, and presence of anxiety was associated
with a lower FEV1 % predicted. This suggests that there
is an objective association between anxiety and uncon-
trolled asthma, although the causal link remains unclear.
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